Phase 2 as Related to the DOH Survey Process Pharmacy Services - - PowerPoint PPT Presentation

phase 2 as related to the doh survey process
SMART_READER_LITE
LIVE PREVIEW

Phase 2 as Related to the DOH Survey Process Pharmacy Services - - PowerPoint PPT Presentation

Phase 2 as Related to the DOH Survey Process Pharmacy Services Richard A. Zelkowitz, RPh, MS, FASCP President, Pharmacon Co. Pharmaceutical Consultants to Health Care Institutions (914) 961-3372 www.PharmaconConsulting.com Phase 2 / DOH


slide-1
SLIDE 1

Phase 2 as Related to the DOH Survey Process Pharmacy Services

Richard A. Zelkowitz, RPh, MS, FASCP President, Pharmacon Co.

Pharmaceutical Consultants to Health Care Institutions (914) 961-3372 www.PharmaconConsulting.com

slide-2
SLIDE 2

Phase 2 / DOH Survey Process

“Final Rule” Implementation Three Phases…

 Phase 1: November 28, 2016  Phase 2: November 28, 2017  Phase 3: November 28, 2019

slide-3
SLIDE 3

Phase 2 / DOH Survey Process

Phase 1

 Drug Regimen Review (DRR)

 Reported to attending physician,

Medical Director and DNS

 Specifies attending physician’s

documentation requirement in response to DRR recommendations.

 If disagree, why?

slide-4
SLIDE 4

Phase 2 / DOH Survey Process

 Phase 1, cont.

 Policies/Procedures need to address

 Time frames for each step of the DRR process  Pharmacist actions when need for urgent action

to protect resident

slide-5
SLIDE 5

Phase 2 / DOH Survey Process

Phase 2 483.45 Pharmacy Services

Redefines “Antipsychotic” to “Psychotropic”

 Definition expanded to include

 Anti-psychotic  Anti-depressant  Anti-anxiety  Hypnotic

ALL REQUIRE GRADUAL DOSE REDUCTION

slide-6
SLIDE 6

Phase 2 / DOH Survey Process

Phase 2 483.45 Pharmacy Services

 Psychotropic PRN Orders limited to 14 days

 Unless Physician documents rationale and

indicates duration of the PRN order.

 This includes meds other than antipsychotics

 Anti-anxiety (Ativan, Xanax)  HYPNOTICS ( Ambien, Restoril)

 Alternative : MELATONIN

slide-7
SLIDE 7

Phase 2 / DOH Survey Process

Phase 2 483.45 Pharmacy Services

 ANTIPSYCHOTIC PRN Orders limited to 14

days

 Cannot be renewed unless the physician evaluates

for the appropriateness of that medication.

Use of Antipsychotic PRN’s are a Major Survey Risk as an Unnecessary Medication

slide-8
SLIDE 8

Phase 2 / DOH Survey Process

 Survey Risk Areas

 Nursing Station Inspections  Medication Pass  Documentation

slide-9
SLIDE 9

Phase 2 / DOH Survey Process

 Nursing Station Inspection

 Refrigerator

 Temperature 36-46 degrees F

 Keep Temperature Log

 Open Multi-dose Vials & Pens

 Must be dated when opened  Discard after expiration date (varies)  Refrigerator should be checked on a daily basis

slide-10
SLIDE 10

Phase 2 / DOH Survey Process

 Food Storage

 Only in Pantry area  None in medication room or REFRIGERATOR

 Discharged, Discontinued & Patient Property

 Must be segregated

 Suppositories

 Store as per manufacturer’s guidelines  Room Temperature – In container in medication

cabinet

 Cool or Cold – In refrigerator

slide-11
SLIDE 11

Phase 2 / DOH Survey Process

 Medication Cart

 Dating of open containers

 Xalatan – 6 weeks from opening  Advair – 30 days from opening  Protein Supplements – 30 days  Glucose Control Solutions – 30 days

 Expired medications

 Old blister cards – PRN meds over 90 days  Stock medications  Nebulizer Solutions – Albuterol & Ipratropium

slide-12
SLIDE 12

Phase 2 / DOH Survey Process

 Controlled Medications

 Control Cabinet

 Metal, Double-locked (2 doors), TWO

DIFFERENT KEYS, Mounted on the wall

 Same regulations apply to refrigerator.  Controlled medications must be removed from

medication cart after medication pass

 Only controlled medication stored in cabinet –

No syringes, No jewelry, No wallets, No hearing aides or batteries. AVIOD CONSTANT OPENING

slide-13
SLIDE 13

Phase 2 / DOH Survey Process

 Shift Audit

 NO BLANK SIGNATURE BOXES  All shifts must reconcile controlled

medication count

 Reconciliation of controlled medications

by 2 nurses

 Separate sheet for each Rx

slide-14
SLIDE 14

Phase 2 / DOH Survey Process

Date Received Resident Name and Room # Drug Name & Strength Rx # Quantity Physician RN Signature Signature

  • f

Receiving Nurse Anticipated Date of Return Quantity Returned Date Returned

CONTROLLED DRUG RECEIPT LOG

slide-15
SLIDE 15

Phase 2 / DOH Survey Process

 Release of Control Medication Upon

Discharge

 Physician must write order stating

medication, strength and amount

 Must sign waiver for non-childproof

container

 Release only to responsible party - not

ambulance driver

slide-16
SLIDE 16

Phase 2 / DOH Survey Process

 Emergency Kit

 Must be sealed

 Preferably with serial number on lock  Expiration date must be clearly discernable  Content list must agree with contents

  • Should have name and date of sealing Pharmacist
  • Use Swap System , Do not send individual medications

 Controlled Medication Emergency Kit

 Stored separately from routine controlled medications  Must be counted each shift by nursing personnel  Par levels MUST be maintained by informing vendor

pharmacy each time medication is used

slide-17
SLIDE 17

Phase 2 / DOH Survey Process

 Medication Pass

 Gastrostomy Tube: Infection Control  Dilantin Suspension via G-Tube

 Must be separated from feeding – hold feed,

wait 60 minutes, flush tube, administer, flush tube, wait 60 minutes, restart feed

 Viscous Medication Via G-Tube

 Dilute  Watch for residue in cup

slide-18
SLIDE 18

Phase 2 / DOH Survey Process

 Common Errors

 Wrong Number of Tablets Administered

 Highlight label and MAR

 Check ID  Wait 3 minutes between 2 drops of same

  • phthalmic medication

 Wait 1 minute between each “puff” of

inhaler.

slide-19
SLIDE 19

Phase 2 / DOH Survey Process

 Measurement of Liquids

 On flat surface  At eye level  Use proper size water cup (5 oz. vs. 8 oz.)

 Charting Omissions & Transcription Errors

 Considered medication errors  Check at end of shift

 Unavailable Medication / Delay of Delivery

 Do not borrow  Do not chart “unavailable”  Contact your pharmacy for availability (via supervisor)  Contact physician for further orders  “Hold until available”

slide-20
SLIDE 20

Phase 2 / DOH Survey Process

 Crush vs. Liquid

 If medication is available in liquid form, even if

it is crushable, Physician should order the medication in liquid form

 Crush only with MD order  EACH MEDICATION CRUSHED SEPARATELY

 Infection Control

 HANDWASHING  Gloves should be worn for all Injectable

Administration

slide-21
SLIDE 21

Phase 2 / DOH Survey Process

 Medication Strength & Type

 Make sure that actual strength and type of

stock medication is the same as the medication

  • rder.

 Examples:

 Calcium with Vitamin D  Fish Oil/Omega 3  Nephrocaps  Vitamin D2 vs. Vitamin D3  Regular vs. Enteric Coated Aspirin

slide-22
SLIDE 22

Phase 2 / DOH Survey Process

DOCUMENTATION

Medication orders

Strength and quantity of liquids

Route of Administration

Must be consistent – PO or G/T

Medication Indication for Use

Antipsychotic – Must have Psychotic Indication (NOT DEMENTIA OR AGITATION)

Schizophrenia, Bipolar

NON-PHARMACOLOGIC INTERVENTIONS MUST BE TRIED FIRST (EVEN AFTER FAILED GDR)

slide-23
SLIDE 23

Phase 2 / DOH Survey Process

 PRN Use – Reason and Follow-Up

 Anti-anxiety Medication  Must document failure of behavioral interventions  Caution with use, MAY BE CONSIDERED CHEMICAL

RESTRAINTS.

 14 day limit  Analgesics  Acetaminophen < 3 gm/day

 Interactions

 Synthroid & Calcium  Levaquin & Iron  WARFARIN

slide-24
SLIDE 24

Phase 2 / DOH Survey Process

 Medication Refusal

 Proper documentation by nursing and physician  Proper destruction of refused dose

 Crush and destroy in water

 Prevnar 13 vs. Pneumovax 23

 Check CMS site if previously administered  Prevnar first  One year (and one day) in between

slide-25
SLIDE 25

Phase 2 / DOH Survey Process

 TREATMENT OF PAIN

 Frequent use of PRN Medications

 Order as routine

 Use of 2 or more analgesics

 Document need and efficacy  Use pain scale

 Pre-treatment analgesia

 Must be timed properly

slide-26
SLIDE 26

Phase 2 / DOH Survey Process

 MONITORING

 Warfarin

 INR: ordered, picked up, obtained, MD notified  Increased monitoring with antibiotics  Administer at 9 PM (allow time to adjust re: lab work)

 Anti-Diabetic

 Fingerstick – NO GAPS, Follow sliding scale  Is Sliding Scale needed??

 Anti-Hypertensive

 BP Parameters – NO GAPS  MINIMIZE USE OF HOLD PARAMETERS

slide-27
SLIDE 27

Phase 2 / DOH Survey Process

 Laboratory Tests

 Results should be filed in a timely manner  Results should be signed and noted by

physician

 Psychiatric Consults

 Should be done at least every 3 to 6 months  Attempt at dose reduction or reason why not

 “I have personally assessed this resident to

determine the need for a GDR and because he/she has a diagnosed enduring condition of _______, a GDR is clinically contra-indicated at this time.”

 Benefit vs. Risk

slide-28
SLIDE 28

Phase 2 / DOH Survey Process

 New Concerns

 Interim MRR for new admission, significant

change and short term residents

 Must have system in place  May be done off-site

slide-29
SLIDE 29

Phase 2 / DOH Survey Process

Questions?

rzelkowitz@pharmaconconsulting.com